On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical University, Wuxi People's Hospital Affiliated to ...

Corinne Van Hoven, a senior honors medical diagnostics major, spent the summer conducting cancer research at Fox Chase Cancer ...

Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...

Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by ...

Learn more about whether Zai Lab Limited or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The higher the deduction, the lower the payout ratio in insurance claims, which often leads the family to bear significant ...

Results Underscore PRP Candidacy as a Disruptor of the Tumor MicroenvironmentMELBOURNE, Australia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”) ...

On October 3, 2025, a multicenter team from Shenzhen University, Xiangya Hospital of Central South University, Zhujiang Hospital of Southern Medical ...

CD8⁺ T cells are central effectors of antitumor immunity, capable of recognizing and eliminating malignant cells. Their presence within tumors often ...

As head team physician for the New York Giants, I routinely have athletes asking about supposed ‘breakthrough’ stem cell ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, driven by marked molecular and clinical heterogeneity and ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.